International Consultant- Pharmacovigilance Systems Strengthening

%3Ctable class=%22Mso. Normal. Table%22 style=%22border-collapse:collapse;border-style:none;mso-border-alt:solid windowtext .5pt;mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid windowtext;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-table-layout-alt:fixed;mso-yfti-tbllook:480;%22 border=%221%22 cellspacing=%220%22 cellpadding=%220%22 width=%22650%22%3E%3Ctbody%3E%3Ctr style=%22height:20.

8pt;mso-yfti-firstrow:yes;mso-yfti-irow:0;%22%3E%3Ctd style=%22border-color:windowtext;border-width:1.0pt;height:20.8pt;mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22margin:3.0pt 0in 3.0pt 24.1pt;mso-list:l6 level1 lfo1;page-break-after:avoid;tab-stops:list 24.

0pt right 6.0in center 468.05pt;text-indent:-24.1pt;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E1.%3C/strong%3E%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EObjectives%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:42.

55pt;mso-yfti-irow:1;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:42.55pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso.

Normal%22 style=%22text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-ansi-language:EN-US;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22%3EThe overall objective of engaging a consultant is to accelerate implementation of PV IDPs to attain ML3 for vigilance functions.

%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-ansi-language:EN-US;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22%3E%3Cstrong%3ESpecific Objectives%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso.

List. Paragraph%22 style=%22mso-list:l5 level1 lfo7;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-list:Ignore;%22%3E1.

%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3ETo conduct a comprehensive baseline GBT assessment, assist in review of guidelines, SOPs, assessment tools, GBT evidence and provide guidance essential for fulfilling the identified IDPs.

%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22mso-list:l5 level1 lfo7;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-list:Ignore;%22%3E2.

%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EIntegrate GBT IDP implementation to promote compliance by industry, public health entities and national regulatory requirements.

%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22mso-yfti-irow:2;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.

0pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22margin:3.0pt 0in 3.0pt 24.1pt;mso-list:l6 level1 lfo1;page-break-after:avoid;tab-stops:list 24.0pt right 6.0in center 468.05pt;text-indent:-24.

1pt;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E2.%3C/strong%3E%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EScope of Work%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:42.

55pt;mso-yfti-irow:3;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:42.55pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso.

Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-AU;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-AU%22%3E%3Cstrong%3EOutput 1.

1:%3C/strong%3E%3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E Conduct a detailed landscape and SWOT analysis of vigilance systems within the BoMRA and related stakeholders in Botswana.

%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight:normal;%22%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EOutput 1.

2:%3C/strong%3E%3C/span%3E%3C/b%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E Review guidelines, Standard Operating Procedures (SOPs) working tools, and regulatory actions and decisions aligned with WHO Global benchmarking standards.

%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight:normal;%22%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EOutput 1.

3%3C/strong%3E%3C/span%3E%3C/b%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E: Provide review of%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List.

Paragraph%22 style=%22line-height:115%;mso-list:l0 level1 lfo2;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E-%3C/span%3E%3Cspan style=%22font:7.

0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ansi-language:EN-GB;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EEvaluation of %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3ERisk Management Planning (RMP) and related documents%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso.

List. Paragraph%22 style=%22line-height:115%;mso-list:l0 level1 lfo2;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E-%3C/span%3E%3Cspan style=%22font:7.

0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3ESafety Communication and Vigilance data Publication%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso.

List. Paragraph%22 style=%22line-height:115%;mso-list:l0 level1 lfo2;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E-%3C/span%3E%3Cspan style=%22font:7.

0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ansi-language:EN-GB;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EV%3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3Eigilance documents during conduct of Good Vigilance Inspections%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso.

List. Paragraph%22 style=%22line-height:115%;mso-list:l0 level1 lfo2;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E-%3C/span%3E%3Cspan style=%22font:7.

0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EImplementation of IDPs at Adverse Drug Reaction Monitoring Centres (AMCs) against%26nbsp;the Field Visit Manual for Assessing the Performance of Vigilance Function%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso.

List. Paragraph%22 style=%22line-height:115%;mso-list:l0 level1 lfo2;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight:normal;%22%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EOutput 1.

4%3C/strong%3E%3C/span%3E%3C/b%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E: Provide guidance on communication to BoMRA stakeholders on%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso.

List. Paragraph%22 style=%22line-height:115%;mso-list:l0 level1 lfo2;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E-%3C/span%3E%3Cspan style=%22font:7.

0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ansi-language:EN-GB;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EA%3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3Ectivities %3C/span%3E%3Cspan style=%22mso-ansi-language:EN-GB;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3Eto be conducted to%3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3E enhance understanding and compliance to regulations%3C/span%3E%3Cspan style=%22mso-ansi-language:EN-GB;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E and guidelines%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso.

Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:.3in;mso-yfti-irow:4;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.

0pt;height:.3in;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22margin:3.0pt 0in 3.0pt 24.1pt;mso-list:l6 level1 lfo1;page-break-after:avoid;tab-stops:list 24.0pt right 6.0in center 468.

05pt;text-indent:-24.1pt;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E3.%3C/strong%3E%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EDeliverables:%3C/strong%3E%3C/span%3E%3C/span%3E%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:42.

55pt;mso-yfti-irow:5;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:42.55pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso.

List. Paragraph%22 style=%22line-height:115%;mso-list:l1 level1 lfo3;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.

0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EMonthly Progress Reports

• Monthly written reports summarizing:%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22line-height:115%;margin-left:39.0pt;mso-list:l7 level1 lfo4;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EActivities conducted Progress against IDP milestones%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22line-height:115%;mso-list:l1 level1 lfo3;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EChallenges encountered and mitigation actions%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22line-height:115%;mso-list:l1 level1 lfo3;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3ERecommendations for the next period%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22line-height:115%;mso-list:l1 level1 lfo3;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EComprehensive end of activity report on vigilance systems within the BoMRA and stakeholders, including activities conducted and recommendations on how to strengthen existing systems.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22line-height:115%;mso-list:l1 level1 lfo3;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EGBT implementation status %26gt;95% completion by March 2027.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22line-height:115%;mso-list:l1 level1 lfo3;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EReview of training materials, including presentations, handouts, and session summaries for safety surveillance and causality assessment.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22line-height:115%;mso-list:l1 level1 lfo3;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Batang;mso-fareast-language:EN-US;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3ERecommendations for sustaining and accelerating progress%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22mso-yfti-irow:6;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22margin:3.0pt 0in 3.0pt 24.1pt;mso-list:l6 level1 lfo1;page-break-after:avoid;tab-stops:list 24.0pt right 6.0in center 468.05pt;text-indent:-24.1pt;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight:normal;%22%3E%3Cspan style=%22mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E4.%3C/strong%3E%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EQualifications, experience, skills and languages%3C/strong%3E%3C/span%3E%3C/b%3E%3C/span%3E%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:42.55pt;mso-yfti-irow:7;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:42.55pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Normal%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Normal%22 style=%22text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight:normal;%22%3E%3Ci%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EQualifications%3C/strong%3E%3C/span%3E%3C/i%3E%3C/b%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-font-style:italic;mso-bidi-theme-font:minor-latin;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EAdvanced degree in pharmacy, public health, regulatory science, or related field%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Ci style=%22mso-bidi-font-style:normal;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3EExperience%3C/strong%3E%3C/span%3E%3C/i%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;margin-left:.25in;mso-list:l4 level1 lfo5;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22color:black;font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-US;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-list:Ignore;mso-themecolor:text1;%22%3E-%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;line-height:115%;mso-ansi-language:EN-US;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-list:Ignore;mso-themecolor:text1;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3C/span%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Sim. Sun;mso-fareast-language:EN-US;mso-fareast-theme-font:minor-fareast;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cu%3EEssential%3C/u%3E%3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Sim. Sun;mso-fareast-language:EN-US;mso-fareast-theme-font:minor-fareast;mso-hansi-theme-font:minor-latin;%22 lang=%22RU%22%3E%3Cu%3E:%3C/u%3E%26nbsp;%3C/span%3E%3C/span%3E%3Cspan style=%22color:black;font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-US;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Sim. Sun;mso-fareast-language:EN-US;mso-fareast-theme-font:minor-fareast;mso-hansi-theme-font:minor-latin;mso-spacerun:yes;mso-themecolor:text1;%22%3E %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-US;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Sim. Sun;mso-fareast-language:EN-US;mso-fareast-theme-font:minor-fareast;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22%3EExperience working in the medicine regulatory authority/agency and over %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3E5%3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22RU%22%3E years of relevant work experience in pharmacovigilance, vaccine safety, %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3Ebenefit-risk aggregated report review and %3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22RU%22%3Erisk management %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3Eplanning%3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22RU%22%3E with a focus on risk minimisation measures%3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3E.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;margin-left:.25in;mso-list:l4 level1 lfo5;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;margin-left:.25in;mso-list:l4 level1 lfo5;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22color:black;font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22line-height:115%;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-list:Ignore;mso-themecolor:text1;%22 lang=%22RU%22%3E-%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;line-height:115%;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-list:Ignore;mso-themecolor:text1;%22 lang=%22RU%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3E%3Cu%3EDesirable:%3C/u%3E %3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22RU%22%3EExperience with WHO Global %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3EB%3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22RU%22%3Eenchmarking %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3ET%3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22RU%22%3Eools%3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;mso-themecolor:text1;%22 lang=%22EN-GB%22%3E and/or ICH/EMA guidelines.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;margin-left:.25in;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Ci style=%22mso-bidi-font-style:normal;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-fareast-language:EN-US;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3ESkills/Knowledge%3C/strong%3E%3C/span%3E%3C/i%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;margin-left:.25in;mso-list:l2 level1 lfo6;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-US;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-list:Ignore;%22%3E-%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;line-height:115%;mso-ansi-language:EN-US;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22RU%22%3EExpert in the field of: pharmacovigilance, vaccine safety%3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E and%3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E %3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3Emedicine %3C/span%3E%3Cspan style=%22line-height:115%;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22RU%22%3Erisk management review%3C/span%3E%3Cspan style=%22line-height:115%;mso-ansi-language:EN-GB;mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. No. Spacing%22 style=%22text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. No. Spacing%22 style=%22text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Ci style=%22mso-bidi-font-style:normal;%22%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3ELanguages and level required%3C/strong%3E%3C/span%3E%3C/i%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. List. Paragraph%22 style=%22margin:0in 0in 3.0pt .25in;mso-list:l2 level1 lfo6;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;%22%3E%3Cspan style=%22mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E-%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-font-family:%26quot;. Gill Sans MT%26quot;;mso-fareast-language:EN-US;mso-list:Ignore;%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-language:EN-US;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;%22%3EFluent in English (spoken and written).%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Plain. Text%22 style=%22line-height:115%;margin-left:.25in;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22mso-yfti-irow:8;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22margin:3.0pt 0in 3.0pt 24.1pt;mso-list:l6 level1 lfo1;page-break-after:avoid;tab-stops:list 24.0pt right 6.0in center 468.05pt;text-indent:-24.1pt;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cb style=%22mso-bidi-font-weight:normal;%22%3E%3Cspan style=%22mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E5.%3C/strong%3E%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3ETechnical Supervision%3C/strong%3E%3C/span%3E%3C/b%3E%3C/span%3E%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:24.7pt;mso-yfti-irow:9;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:24.7pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in 467.8pt;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EOn a day-to-day basis, the consultant will report to:%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22margin-left:.5in;mso-list:l3 level1 lfo8;tab-stops:right 6.0in 467.8pt;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-bidi-font-weight:bold;mso-fareast-font-family:Symbol;mso-list:Ignore;%22 lang=%22EN-GB%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-bidi-font-weight:bold;mso-fareast-font-family:Symbol;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EDr Parthasarathi Gurumurthy, Chief Regulatory Officer (Ag), Botswana Medicines Regulatory Authority, %3C/span%3E%3C/span%3E%3Ca href=%22mailto:[email protected]%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%[email protected]%3C/span%3E%3C/span%3E%3C/a%3E%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22margin-left:.5in;mso-list:l3 level1 lfo8;tab-stops:right 6.0in 467.8pt;text-align:justify;text-indent:-.25in;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-list:Ignore;%22 lang=%22EN-GB%22%3E·%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-bidi-font-family:Symbol;mso-fareast-font-family:Symbol;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/span%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EMr Lebogang Koitsiwe, Director Pharmacovigilance and Clinical Trials (Ag), Botswana Medicines Regulatory Authority, %3C/span%3E%3C/span%3E%3Ca href=%22mailto:[email protected]%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%[email protected]%3C/span%3E%3C/span%3E%3C/a%3E%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in 467.8pt;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in 467.8pt;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EOverall contractual oversight will be provided by Dr. Fabian NDENZAKO, WHO Representative%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in 467.8pt;text-align:justify;text-justify:inter-ideograph;%22%3E%26nbsp;%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22mso-yfti-irow:10;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22margin:3.0pt 0in 3.0pt 24.1pt;mso-list:l6 level1 lfo1;page-break-after:avoid;tab-stops:list 24.0pt right 6.0in center 468.05pt;text-indent:-24.1pt;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Cspan style=%22mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E6.%3C/strong%3E%3C/span%3E%3Cspan style=%22font:7.0pt %26quot;. Times New Roman%26quot;;mso-fareast-font-family:Helvetica;mso-list:Ignore;%22 lang=%22EN-GB%22%3E%3Cstrong%3E%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp;%26nbsp; %3C/strong%3E%3C/span%3E%3Cb style=%22mso-bidi-font-weight:normal;%22%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E%3Cstrong%3ELocation%3C/strong%3E%3C/span%3E%3C/b%3E%3C/span%3E%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:19.3pt;mso-yfti-irow:11;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:19.3pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in center 468.05pt;text-align:justify;text-justify:inter-ideograph;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Ci style=%22mso-bidi-font-style:normal;%22%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EOn site%3C/span%3E%3C/i%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-style:italic;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3E: Botswana Medicines Regulatory Authority Head Office, Gaborone, Botswana%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in center 468.05pt;%22%3E%26nbsp;%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in center 468.05pt;%22%3E%3Cspan style=%22font-family:Arial;font-size:11.0pt;%22%3E%3Ci style=%22mso-bidi-font-style:normal;%22%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EOff site: %3C/span%3E%3C/i%3E%3Cspan style=%22mso-ascii-theme-font:minor-latin;mso-bidi-font-style:italic;mso-bidi-font-weight:bold;mso-bidi-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;%22 lang=%22EN-GB%22%3EAudit/Inspection Visits to selected AMCs (e.g. Molepolole, Gaborone, Lobatse, Maun) selected Health Facilities, GVP MAH inspection site as per annual plan.%3C/span%3E%3C/span%3E%3C/p%3E%3Cp class=%22Mso. Footer%22 style=%22tab-stops:right 6.0in center 468.05pt;%22%3E%26nbsp;%3C/p%3E%3C/td%3E%3C/tr%3E%3Ctr style=%22height:19.3pt;mso-yfti-irow:12;%22%3E%3Ctd style=%22border-bottom-style:solid;border-color:windowtext;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:19.3pt;mso-border-alt:solid windowtext .5pt;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt;width:487.35pt;%22 valign=%22top%22 width=%22650%22%3E%3Cp class=%22Mso. Footer%22 style=%22margin:3.0pt 0in 3.0pt 24